Table 1 Patient and lesion characteristics
Patient total (n = 76) | Lesion total (n = 114) | |
|---|---|---|
Age, Median (Range), years | 69 (37–91) | |
Gender, n (%) | ||
ᅟMale | 44 (58%) | |
ᅟFemale | 32 (42%) | |
ECOG PS, n (%) | ||
ᅟ0 | 42 (55%) | |
ᅟ1–2 | 34 (45%) | |
Single lesion, n (%) | 57 (75%) | |
Histology of primary lesion, n (%) | ||
ᅟCRC | 46 (61%) | 73 (64%) |
ᅟNon CRC | 30 (39%) | 41 (36%) |
Previous local therapy, n (%) | 8 (11%) | |
Previous chemotherapy, n (%) | 52 (68%) | 83 (73%) |
Posterior chemotherapy, n (%) | 19 (25%) | 30 (26%) |
Metastatic location, n (%) | ||
ᅟLung | 70 (61%) | |
ᅟLiver | 44 (39%) | |
MTD, Median (Range), mm | 19 (5–57) | |
GTV, Median (Range), ml | 3.2 (0.2–106.8) | |
PTV dose BED10, Median (Range), Gy | 150 (81.3–180) | |